| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 3.047 | 42.497 | 65.048 | 61.064 | 59.972 | 53.423 | 44.476 | 54.900 |
| Total Income - EUR | - | - | 3.047 | 42.681 | 65.564 | 61.500 | 60.173 | 53.683 | 44.621 | 54.934 |
| Total Expenses - EUR | - | - | 1.222 | 13.791 | 25.935 | 24.403 | 21.591 | 20.541 | 23.065 | 17.450 |
| Gross Profit/Loss - EUR | - | - | 1.825 | 28.891 | 39.630 | 37.097 | 38.582 | 33.142 | 21.556 | 37.483 |
| Net Profit/Loss - EUR | - | - | 1.794 | 28.464 | 38.974 | 36.683 | 37.849 | 32.605 | 21.000 | 36.934 |
| Employees | - | - | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Biomedial Regulatory S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 0 | 0 | 0 | 828 | 1.366 | 1.022 | 1.619 | 2.255 |
| Current Assets | - | - | 3.227 | 29.610 | 42.545 | 45.424 | 55.635 | 62.850 | 29.547 | 35.103 |
| Inventories | - | - | 0 | 741 | 0 | 268 | 399 | 0 | 0 | 0 |
| Receivables | - | - | 1.513 | 5.876 | 35.011 | 33.418 | 24.155 | 42.329 | 24.577 | 10.631 |
| Cash | - | - | 1.714 | 22.992 | 7.534 | 11.738 | 31.081 | 20.520 | 4.971 | 24.472 |
| Shareholders Funds | - | - | 1.838 | 28.515 | 39.025 | 36.732 | 37.897 | 32.654 | 21.049 | 36.982 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 1.389 | 1.094 | 3.520 | 9.520 | 19.104 | 31.217 | 10.118 | 376 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7490 - 7490" | |||||||||
| CAEN Financial Year |
7490
|
|||||||||
Comments - Biomedial Regulatory S.r.l.